# Novel MRI Techniques for Pancreatic Cancer

> **NCT04306861** · — · WITHDRAWN · sponsor: **Beth Israel Deaconess Medical Center**

## Conditions studied

- Pancreatic Ductal Adenocarcinoma

## Interventions

- **DIAGNOSTIC_TEST:** MRI

## Key facts

- **NCT ID:** NCT04306861
- **Lead sponsor:** Beth Israel Deaconess Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-03-09
- **Primary completion:** 2022-08-30
- **Final completion:** 2022-08-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Enrollment and other trial activities have temporarily paused due to COVID-19 and are expected to resume in the future; This is not a suspension of IRB approval
- **Last updated:** 2022-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04306861

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04306861, "Novel MRI Techniques for Pancreatic Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04306861. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*